Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.095 USD | +11.73% | +33.05% | -26.37% |
02/05 | CUREVAC : A missed opportunity | |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.37% | 620M | |
+22.77% | 48.09B | |
+46.90% | 40.62B | |
-3.26% | 40.43B | |
-6.20% | 28.36B | |
+9.22% | 24.89B | |
-20.02% | 19.01B | |
+29.04% | 12.09B | |
+0.62% | 11.88B | |
-0.92% | 11.8B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Reports Disappointing Study Results for COVID-19 Vaccine, Driving Shares Lower